Dallas, March 03, 2022 (GLOBE NEWSWIRE) -- As per the report published by The Brainy Insights, the global pharmacogenomics (PGx) market is expected to grow from USD 6.73 billion in 2020 to USD 11.63 ...

PGX has an asymmetric return profile. Moves to the upside are capped, whereas it participates fully in selloffs. While the preferred shares that PGX owns are structurally senior to common equity, debt ...

The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects ...

The PGX ETF provides exposure to an index of fixed-rate preferred shares. PGX pays a generous 5.8% trailing distribution yield. Historically, PGX total returns are primarily driven by interest rates ...

Invesco Preferred ETF's next dividend was announced on February 12, 2013 and will have an ex-dividend date of Invalid DateTime. There are no upcoming dividends for Invesco Preferred ETF.The last ...

Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced plans to launch FoundationOne ® PGx, a pharmacogenetic (PGx) offering to identify genetic differences ...

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco Preferred ETF (Symbol: PGX) where we have detected an ...

Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy ...

Dietary factors that help control perceived hunger might improve adherence to calorie-reduced diets. Recently, PolyGlycopleX (PGX), a novel, highly viscous non-starch polysaccharide complex has been ...

Assess whether PGX fits your portfolio by analysing key metrics including dividend yield (where relevant), expense ratio, holdings composition and long-term performance trends. Compare asset ...